Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04378439 · ClinicalTrials.gov registry record · NA

Appalachian Partnership to Reduce Disparities (Aim 2)

A NA study of HIV/AIDS and HCV, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
141
Enrollment target
1
Study location

NCT04378439 is a NA study of HIV/AIDS and HCV that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 141 participants, below the 33,178-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04378439, a NA study of HIV/AIDS and HCV, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
141 participants
Enrollment target
1
Study location

Study Summary

By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia. Study Investigators anticipate that participants in the intervention group, relative to counterparts in the delayed-intervention group, will demonstrate increased HIV, STI, and HCV testing.

Conditions Studied

Interventions

  • BEHAVIORAL mHealth
  • BEHAVIORAL Peer Navigation

Study Locations (1)

North Carolina

  • Wake Forest University Health Sciences - Winston-Salem

Trial Details

FieldValue
Enrollment Target 141 participants
Start Date 2022-04-01
Est. Completion 2026-05
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04378439

The ClinicalTrials.gov registry entry for NCT04378439 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 141 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 33,178-participant average among 61 other HIV/AIDS trials with a reported enrollment target (100% lower). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with HIV/AIDS appearing as the primary indexed condition, and to 2 interventions - of which mHealth is the first listed.

NCT04378439 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT04378439 about?

NCT04378439 is a clinical study titled "Appalachian Partnership to Reduce Disparities (Aim 2)". By combining two strategies (i.e., peer navigation and mHealth) into a complete, culturally compatible, bilingual intervention to increase the use of needed HIV, STI, and HCV prevention and care services among racially/ethnically diverse GBMSM and transgender women in rural Appalachia. Study Invest...

What is the current status of trial NCT04378439?

This trial is currently recruiting. It is a NA study. The enrollment target is 141 participants. The study started on 2022-04-01. Estimated completion is 2026-05.

What conditions does trial NCT04378439 study?

This clinical trial studies the following conditions: HIV/AIDS, HCV, STI.

What interventions are being tested in trial NCT04378439?

The interventions under investigation include: mHealth (BEHAVIORAL), Peer Navigation (BEHAVIORAL).

Who is sponsoring clinical trial NCT04378439?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04378439 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV/AIDS

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.